516 results
Summary and take home messages of the late-breaking clinical trials presented during #TCTConnect 2020
19 Oct 2020
Vijay Kunadian provides a summary of the coronary & structural late-breaking studies presented during TCT Connect 2020 and shares some take-home messages. See how these studies might influence your daily practice!

Author

PCRonline @ TCT Connect 2020
25 Sep 2020
View reviews and take-home messages from a selection of major Late-breaking Clinical Trials in Interventional Cardiology released at the 2020 online edition of TCT Connect. Check out the list here!

Cisplatin-induced coronary artery thrombosis presented as acute coronary syndrome
16 Sep 2020
Consult this case of a 38-year-old male who presented in the ER with acute chest pain after he had received first cycle of chemotherapy with cisplatin, bleomycin and etoposide for gestational cell tumour with mesenteric mass. The angiogram showed grade IV thrombus in proximal LAD...
Author

Clinical outcomes of calcified nodules detected by optical coherence tomography: a sub-analysis of the CLIMA study
10 Sep 2020
The goal of the present post hoc analysis of the CLIMA registry was to establish the relationship between calcified nodules (CNs) with (CND) or without (CNWD) disruption of the superficial intimal fibrous layer and one-year occurrence of target lesion myocardial infarction (MI) and/or cardiac death.
Authors :

REALITY - A trial of transfusion strategies for myocardial infarction and anemia
03 Sep 2020
ESC Congress 2020: Tabassome Simon (Paris, France) discusses with Francesco Costa the results of REALITY trial which supports the use of a restrictive strategy for blood transfusion in MI patients with anemia.

Author

When medical history can guide therapeutic choices: an uncommon case of STEMI
26 Aug 2020
In this unusual STEMI case of a 75 year old hypertensive woman, find out how medical history can guide the therapeutic choices and how the interventional cardiologist can resist stent implantation...
Author

MIRTOS trial: Ticagrelor versus Clopidogrel in patients with STEMI treated with thrombolysis
07 Aug 2020
The MIRTOS trial, which included STEMI patients receiving DAPT and thrombolysis ‘together’, aimed to evaluate whether ticagrelor could improve microvascular perfusion and reduce MACE compared to clopidogrel

Reviewer

Reviewer

Cangrelor, Tirofiban and Chewed or Standard Prasugrel Regimens in Patients with ST-Segment Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial
15 Jul 2020
The results of the FABOLUS FASTER trial clearly highlight that a high residual platelet reactivity persists when targeting platelet activation by inhibition of the P2Y12 receptor either with Prasugrel or Cangrelor, while tackling the mechanism of platelet adhesion thought the inhibition of GPIIB/IIIA might almost completely...

Reviewer

PCRonline @ ESC Congress 2020: the digital experience
25 Aug 2020
Make sure you stay up to date with what's new and hot in interventional cardiology.

PCR Trials: Ticagrelor versus Clopidogrel in ACS and invasive management (TICAKOREA)
24 Jul 2020
The objective of this study is to compare the safety and efficacy of ticagrelor with clopidogrel in patients with ACS.
Authors :
